CD63 and hepatocellular carcinoma: To confirm EIF3C expression increased release of exosomes in HCC cells, we detected protein expression of exosome biomarkers in exosomes including ALIX, TSG101, CD9, CD63 and CD81 as positive as well as GM130 as negative controls by Western blotting analysis [35–37].